CareLit Fachartikel

Effectiveness of peptide receptor radionuclide therapy for neuroendocrine neoplasms; a multi-institutional registry study with prospective follow up

D Hörsch · Zeitschrift für Gastroenterologie · 2013 · Heft 08

Dokument
1142749
CareLit-ID
Jahr
2013
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
D Hörsch
Ausgabe
Heft 08 / 2013
Seiten
–
Erschienen: 2013-08-16 00:00:00
ISSN
0044-2771
DOI
10.1055/s-0033-1352718

Zusammenfassung

Aims: Peptide receptor radionuclide therapy targets somatostatin receptors expressed on well differentiated neuroendocrine neoplasms. Retrospective monocentric studies indicate that peptide receptor radionuclide therapy is an effective treatment for patients with neuroendocrine neoplasms. Patients and methods: We initiated a multi-institutional, prospective and board reviewed registry for patients treated with peptide receptor radionuclide therapy. 450 patients were included and followed for a mean of 24.4 months. Patients were treated with Lutetium-177 (54%), Yttrium-90 (17%) or both radionuclides (29%). Primar…

Schlagworte

Months Neuroendocrine Patients Therapy Neoplasms Median Peptide Receptor Radionuclide Primary Survival Unknown Zeitschrift für Gastroenterologie